MedTrace Logo

Feasibility Study of Telemedicine for Dialysis Patients Awaiting Transplantation

NCT03189212 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2023-01-12

No results posted yet for this study

Summary

The purpose of this study is to determine whether a telemedicine follow-up visit at the NYU Langone Transplant Institute is a feasible and acceptable alternative to a traditional in-center follow-up visit.

Conditions

Interventions

BEHAVIORAL

Usual Care Visit

Routine 6-month follow up appointment at the NYULMC transplant center

BEHAVIORAL

Telemedicine Visit

TM visit conducted at the patient's dialysis unit as a replacement to usual 6 month routine f/u visit

Sponsors & Collaborators

Principal Investigators

  • Nicole Ali, MD · NYU Langone Health

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-01
Primary Completion
2021-01-19
Completion
2021-01-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03189212 on ClinicalTrials.gov